Whole genome sequencing shows promise in fight against AMR
The use of whole genome sequencing can improve the way antimicrobial resistance (AMR) is monitored in food and animals, EFSA says in a new report published today. Ahead of the revised legislation on AMR monitoring that is due to come into force in 2021, EFSA suggests that these methods could gradually be introduced into Member State monitoring activities.
Using whole genome sequencing, experts can identify resistant genes in bacteria as opposed to current phenotypical methods which test bacteria for resistance to specific antibiotics. This not only has the potential to predict AMR more efficiently but also generates a large amount of data which can be used for other epidemiological studies and analysis.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.